Report Highlights
The Pharmaceutical and Healthcare latest pipeline guide Coronary Artery Disease (CAD) (Ischemic
Heart Disease) - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics
under development for Coronary Artery Disease (CAD) (Ischemic Heart Disease) (Cardiovascular),
complete with analysis by stage of development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of
the therapeutics, its complete research and development history and latest news and press
releases.
The Coronary Artery Disease (CAD) (Ischemic Heart Disease) (Cardiovascular) pipeline guide also
reviews of key players involved in therapeutic development for Coronary Artery Disease (CAD)
(Ischemic Heart Disease) and features dormant and discontinued projects. The guide covers
therapeutics under Development by Companies /Universities /Institutes, the molecules developed
by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical and Discovery stages are
3, 3, 17, 7, 18 and 1 respectively. Similarly, the Universities portfolio in IND/CTA Filed and
Discovery stages comprises 1 and 1 molecules, respectively.
Request a Sample Copy of This Report @
http://www.radiantinsights.com/research/coronary-artery-disease-cad-ischemic-heart-
disease-pipeline-review-h1-2017/request-sample
Coronary Artery Disease (CAD) (Ischemic Heart Disease) (Cardiovascular) pipeline guide helps in
identifying and tracking emerging players in the market and their portfolios, enhances decision
making capabilities and helps to create effective counter strategies to gain competitive advantage.
The guide is built using data and information sourced from Global Markets Direct's proprietary
databases, company/university websites, clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university sites and industry-specific third
party sources. Additionally, various dynamic tracking processes ensure that the most recent
developments are captured on a real time basis.
Scope
The pipeline guide provides a snapshot of the global therapeutic landscape of Coronary Artery
Disease (CAD) (Ischemic Heart Disease) (Cardiovascular).
The pipeline guide reviews pipeline therapeutics for Coronary Artery Disease (CAD) (Ischemic
Heart Disease) (Cardiovascular) by companies and universities/research institutes based on
information derived from company and industry-specific sources.
The pipeline guide covers pipeline products based on several stages of development ranging
from pre-registration till discovery and undisclosed stages.
Follow Us: